Viewing Study NCT01667692


Ignite Creation Date: 2025-12-24 @ 3:28 PM
Ignite Modification Date: 2026-02-26 @ 11:54 PM
Study NCT ID: NCT01667692
Status: COMPLETED
Last Update Posted: 2012-08-17
First Post: 2012-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Aizthromycin or Clarithromycin in H-pylori Eradication Regimen
Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services
Organization:

Study Overview

Official Title: Comparison of Azithromycin or Clarithromycin in 3drugs Protocol of H-pylori Eradication Regimen
Status: COMPLETED
Status Verified Date: 2012-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: H-pylori
Brief Summary: The Aim of this study is comparison between two regimens containing clarithromycinand azithromycin.
Detailed Description: Eradication of helicobacter pylori is important for treatment of GU but ideal regimen is not available.

HP is resistant to metronidazole and clarithromycin, thus clarithromycin is expensive and it is not available in underdevelopment countries.

There are different articles about replacement clarithromycin with azithromycin as a method of eradication of HP that is decreases length of therapy and increases, effectiveness of drugs and decreases resistance of drugs.

The Aim of this study is comparison between two regimens containing clarithromycinand azithromycin.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: